Newborns, particularly premature infants, are highly vulnerable during intravenous infusion treatments due to their low immunity, inability to express discomfort, and fragile veins. Chemical ...
After being found effective over longer durations with smaller doses, this study found that nipocalimab infusions resulted in a tolerable safety profile and remained effective even in shorter ...
A randomized phase 2 trial of combretatstatin A4 phosphate (CA4P) in combination with paclitaxel and carboplatin to evaluate safety and efficacy in subjects with advanced imageable malignancies No ...
DENVER — Administering multiple intravenous (IV) infusions is common in the critical care environment, but it increases the potential for errors. Researchers with the HumanEra project at University ...
Anti-TNFR2 monoclonal antibody LBL-019 in patients with advanced malignant tumors: A phase I, first-in-human, open-label, multicenter, dose escalation Study. This is an ASCO Meeting Abstract from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results